このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Midwife-led Childbirth Review and Psychological Outcomes in New Parents (CROWN)

2026年6月25日 更新者:Michal Zikán、Charles University, Czech Republic

Effects of a Midwife-led Childbirth Review on Psychological Outcomes in New Parents

The aim of this clinical trial is to support psychological well-being and facilitate adjustment to parenthood among postpartum mothers and fathers through a midwife-led childbirth review (MLCR). MLCR is a structured 45-60-minute postpartum intervention focused on processing and integration of the individual's childbirth experience, involving active listening, emotional support, and provision of information. In this study, the investigators will employ the MLCR intervention developed by Gamble and Creedy (2009) for women with traumatic birth experiences, adapted for use in the general population of new parents, including both mothers and fathers/partners. This study will compare the effectiveness of three MLCR models - MLCR provided within the first postpartum week, MLCR provided at 6-8 weeks postpartum, and MLCR provided at both time points - with standard postpartum care and with each other.

調査の概要

詳細な説明

Childbirth is a profound experience that may have long-term effects on maternal mental health and psychosocial functioning. While a positive childbirth experience may enhance psychological well-being, a negative childbirth experience has been associated with an increased risk of postpartum mental health difficulties, including post-traumatic stress disorder and postpartum depression.

In maternity care settings, a frequently used intervention aimed at processing childbirth experience is postpartum debriefing, which provides mothers with an opportunity to discuss their birth experience with a healthcare professional, most commonly a midwife. Postpartum debriefing provided by midwives has been integrated into maternity care in some countries and is offered as a targeted intervention to women after traumatic childbirth to reduce postpartum psychological morbidity. In some settings, however, postpartum debriefing is offered universally to all postpartum women; this is in line with qualitative studies showing that most women appreciate midwives initiating discussions about childbirth, listening to their experiences with empathy and support, and providing them with relevant information.

Reviewing childbirth experience with a supportive healthcare professional may help women facilitate understanding and integration of this emotionally and physically demanding event while gaining a sense of closure. Consequently, postpartum debriefing with a midwife may not only reduce the risk of psychiatric problems in women with traumatic childbirth experiences but may also be beneficial for the general population of postpartum women as a supportive intervention promoting psychological adjustment after childbirth. Following Sheen and Slade (2015), we refer to this type of supportive intervention as "childbirth review" to distinguish it from psychological debriefing provided following an adverse event.

Although postpartum debriefing is widely used in maternity care settings and recommended by policymakers, evidence regarding its effectiveness in improving postpartum mental health remains inconsistent and of limited quality. In addition, studies focusing on outcomes such as postpartum anxiety, parenting competence, sleep, social relationships, or future reproductive choices are lacking. Moreover, previous research has focused primarily on postpartum mothers, while largely omitting fathers present at childbirth.

This study aims to address these gaps by evaluating the effectiveness of midwife-led childbirth review (MLCR) offered to all postpartum women, as well as their partners present at childbirth, in order to improve postpartum psychological outcomes. MLCR employed in this study is based on the counselling model developed by Gamble and Creedy (2009) to support women with traumatic births and adapted for the general population of parents in the postpartum period. In this study, MLCR is conceptualized as a supportive discussion about childbirth experience intended to facilitate its understanding and processing in new parents.

MLCR will be delivered by midwives in a structured 45-60-minute session and will include review of the childbirth experience, active listening, emotional support, clarification of childbirth-related events and procedures when needed, and provision of information related to the birth. Mothers and fathers/partners will receive MLCR separately. To ensure intervention consistency, all participating midwives will complete standardized training and receive a detailed intervention manual before study initiation. Supervision procedures and an intervention fidelity plan will be implemented throughout the study. Standard postpartum care will not include the structured MLCR procedure or predefined intervention elements.

Participants (pregnant women and their partners) will be recruited during the third trimester of pregnancy from Bulovka University Hospital in Prague and University Hospital Brno. Data will be collected during late pregnancy, within the first postpartum week, at 6-8 weeks postpartum, and at 6 months postpartum.

Following childbirth and confirmation of study eligibility, women will be randomized to one of four groups: (1) MLCR within the first postpartum week, (2) MLCR at 6-8 weeks postpartum, (3) MLCR at both time points, or (4) standard postpartum care. Randomization will be stratified by key obstetric and psychological characteristics (parity, mode of birth, childbirth experience, psychiatric history). Fathers/partners will be assigned to the same study group as the mother.

The primary outcomes are maternal symptoms of postpartum depression and perinatal anxiety. The primary hypothesis is that mothers receiving any form of MLCR will report lower levels of symptoms of postpartum depression and perinatal anxiety at 6 months postpartum than mothers receiving standard postpartum care. In addition, repeated MLCR will be more effective than single-session MLCR, and early-only and later-only MLCR will differ in their effects on maternal postpartum depression and perinatal anxiety symptoms at 6 months postpartum. At 6-8 weeks postpartum, mothers who received MLCR within the first postpartum week are expected to report lower levels of depressive and anxiety symptoms than mothers who had not yet received MLCR. We will also examine whether baseline depressive and anxiety symptoms during pregnancy moderate the effects of MLCR on postpartum psychological outcomes.

Secondary outcomes for mothers include symptoms of general anxiety, parenting sense of competence, mother-infant bonding, sleep, relationship satisfaction, perceived stress, birth experience, childbirth-related post-traumatic stress symptoms, observed mother-infant interaction quality, and future reproductive choices. Hypotheses tested for secondary outcomes in mothers correspond to those for the primary outcomes.

Data from fathers will be analyzed separately as secondary analyses, as we expect a substantially smaller sample size for fathers. Outcomes/hypotheses related to paternal data will parallel those for maternal data.

研究の種類

介入

入学 (推定)

1300

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

      • Brno、チェコ、60200
        • University Hospital Brno
        • コンタクト:
        • コンタクト:
        • 主任研究者:
          • Andrea Mensikova, PhD, MHM
        • 副調査官:
          • Miloslava Kamenikova, Dr
      • Prague、チェコ、18100
        • Bulovka University Hospital
        • コンタクト:
        • コンタクト:
        • 主任研究者:
          • Michal Zikan, MD, PhD
        • 副調査官:
          • Milada Baresova

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

Pregnant women: Age ≥ 18 years; Singleton pregnancy; Fluency in Czech; Women can enter the study without a partner; Live birth after enrollment. Partners: Partner of an enrolled woman; Age ≥ 18 years; Planning on being present at childbirth; Fluency in Czech

Exclusion Criteria:

Pregnant women: Age < 18 years; Multi-fetal pregnancy; Not being able to read and speak fluent Czech; A severe medical condition including significant pregnancy complications preventing participation in the intervention or assessments; Stillbirth or neonatal death; Infant admitted to intensive care for a prolonged or life-threatening condition; Acute psychiatric condition (suicidality, psychosis, manic episode, substance abuse). Partners: Age < 18 years; Not being able to read and speak fluent Czech; Not planning on being present at childbirth / after recruitment: not present at childbirth; A severe medical condition preventing participation in the intervention or assessments; Stillbirth or neonatal death; Infant admitted to intensive care for a prolonged or life-threatening condition; Acute psychiatric condition (suicidality, psychosis, manic episode, substance abuse)

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Experimental group A
MLCR within the first postpartum week.
MLCR is a structured 45-60 min session that includes review of childbirth experience, active listening, emotional support, clarification of childbirth-related events and procedures when needed, and provision of information related to the birth.
実験的:Experimental group B
MLCR at 6-8 weeks postpartum
MLCR is a structured 45-60 min session that includes review of childbirth experience, active listening, emotional support, clarification of childbirth-related events and procedures when needed, and provision of information related to the birth.
実験的:Experimental group C
MLCR both within the first postpartum week and at 6-8 weeks postpartum
MLCR is a structured 45-60 min session that includes review of childbirth experience, active listening, emotional support, clarification of childbirth-related events and procedures when needed, and provision of information related to the birth.
介入なし:Control group (group D)
Standard postpartum care. This care may include routine clinical communication with healthcare professionals but will not include the structured 45-60 min MLCR intervention or predefined MLCR elements.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Depressive symptoms measured via the Edinburgh Postnatal Depression Scale (EPDS)
時間枠:Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
EPDS is a 10-item self-report questionnaire to screen for postpartum depression but has also been validated for the use in pregnant women. The score may range from 0 to 30, with higher scores indicating higher levels of depressive symptoms.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Perinatal anxiety symptoms measured via the Perinatal Anxiety Screening Scale (PASS)
時間枠:Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
PASS is a 31-item self-report questionnaire developed to screen for a broad range of anxiety symptoms during pregnancy and the postpartum period. It consists of four subscales: Acute Anxiety and Adjustment; General Worry and Specific Fears; Perfectionism, Control and Trauma; Social Anxiety. The score may range from 0 to 93, with higher scores indicating more severe anxiety.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum

二次結果の測定

結果測定
メジャーの説明
時間枠
Anxiety symptoms measured via the State-Trait Anxiety Inventory - state - short 5-item version (STAIS-5)
時間枠:Baseline (third trimester of pregnancy), within the first postpartum week, 6-8 weeks postpartum, 6 months postpartum
STAIS-5 is a 5-item self-report questionnaire assessing state anxiety, i.e. how the person felt at the moment. The score may range from 5 to 20, with higher scores indicating higher levels of state anxiety.
Baseline (third trimester of pregnancy), within the first postpartum week, 6-8 weeks postpartum, 6 months postpartum
Anxiety symptoms measured via the Generalized Anxiety Disorder Scale (GAD-7)
時間枠:Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
GAD-7 is a 7-item scale measuring worry and anxiety symptoms. The score may range from 0 to 21, with higher scores indicating greater anxiety severity.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Maternal parenting self-esteem measured via the Maternal Self-report Inventory (MSRI)
時間枠:Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
MSRI is a 26-item self-report questionnaire measuring maternal parenting self-esteem. The score may range from 26 to 130, with higher scores indicating higher maternal self-esteem. The version for pregnancy contains 12 items.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Parenting self-esteem measured via the Parenting Sense of Competence Scale (PSOC)
時間枠:6 months postpartum
The PSOC is a 17-item self-report questionnaire assessing parenting self-esteem. It consists of two subscales: Satisfaction and Efficacy. The total score may range from 17 to 102, with higher scores indicating higher parenting self-esteem.
6 months postpartum
Maternal bonding to the infant measured via the Maternal Postnatal Attachment Scale (MPAS)
時間枠:6-8 weeks postpartum, 6 months postpartum
MPAS is a 19-item self-report questionnaire measuring maternal emotional tie to her child. MPAS has three subscales: Quality of attachment, Absence of hostility, Pleasure in interaction. The total score may range from 19 to 95, with higher scores indicating better bonding.
6-8 weeks postpartum, 6 months postpartum
Paternal bonding to the infant measured via the Paternal Postnatal Attachment Scale (PPAS)
時間枠:6-8 weeks postpartum, 6 months postpartum
PPAS is a 19-item self-report questionnaire measuring paternal emotional tie to his child. PPAS has three subscales: Patience and tolerance, Pleasure in interaction, Affection and pride. The total score may range from 19 to 95, with higher scores indicating greater bonding.
6-8 weeks postpartum, 6 months postpartum
Sleep quality measured via the Pittsburgh Sleep Quality Index
時間枠:Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
PSQI is a 19-item self-reported questionnaire that assesses sleep quality and disturbances. It consists of 7 component scores: sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping medication, and daytime dysfunction. The total score may range from 0 to 21, with higher scores indicating a poorer sleep quality.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Relationship satisfaction measured via the Relationship Assessment Scale (RAS)
時間枠:Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
RAS is a 7-item questionnaire measuring global relationship satisfaction. The total score may range from 7 to 35, with higher scores indicating higher satisfaction.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Perceived stress measured via the Perceived Stress Scale (PSS)
時間枠:Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
PSS is a 10-item measure detecting how often respondents perceived their lives as stressful, unpredictable, uncontrollable, and overwhelming in the last two weeks. The total score may range from 0 to 40, with higher scores indicating higher levels of perceived stress.
Baseline (third trimester of pregnancy), 6-8 weeks postpartum, 6 months postpartum
Birth experience measured via the Birth Experiences Questionnaire (BEQ)
時間枠:Within the first postpartum week, 6-8 weeks postpartum, 6 months postpartum
BEQ is a 10-item measure designed to assess parents' subjective birth experience, including perceptions of stress, fear, pain, control, partner support, and overall evaluation of childbirth. The total score may range from 10 to 70, with higher scores indicating more negative birth experience.
Within the first postpartum week, 6-8 weeks postpartum, 6 months postpartum
Childbirth-related post-traumatic stress symptoms measured via the City Birth Trauma Scale (CityBiTS)
時間枠:6-8 weeks postpartum, 6 months postpartum
CityBiTS is a 29-item self-report questionnaire assessing post-traumatic stress symptoms following childbirth based on the DSM-5 criteria for PTSD. The total score may range from 0 to 60, with higher scores indicating higher levels of post-traumatic stress symptoms.
6-8 weeks postpartum, 6 months postpartum
Mother-infant interaction quality observed during a free play, assessed via coding scheme developed by Gartstein et al. (2008, 2018)
時間枠:6 months postpartum
The coding scheme developed by Gartstein et al. (2008, 2018) provides ratings for the following domains: maternal sensitivity/responsiveness; synchrony/reciprocity of the dyad; tempo of the interactions; intensity of exchange; emotional tone; and child versus parent directedness. Each domain is rated on a 7-point Likert scale (from 1 to 7) with higher scores reflecting higher levels of the respective attribute. Two composite scores can be created: Engagement and Stimulation.
6 months postpartum
Future reproductive choices assessed via the questionnaire items developed specifically for the purposes of this study.
時間枠:6 months postpartum
Questions focusing on preferred mode of delivery in future childbirth, intention to have another child, and intention to postpone future pregnancy.
6 months postpartum

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • スタディディレクター:Lea Takacs, PhD、Masaryk University
  • 主任研究者:Michal Zikan, MD, PhD、Bulovka University Hospital

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年7月6日

一次修了 (推定)

2028年3月15日

研究の完了 (推定)

2028年7月15日

試験登録日

最初に提出

2026年6月25日

QC基準を満たした最初の提出物

2026年6月25日

最初の投稿 (実際)

2026年7月1日

学習記録の更新

投稿された最後の更新 (実際)

2026年7月1日

QC基準を満たした最後の更新が送信されました

2026年6月25日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • AZV-NW25-09-00321
  • NW25-09-00321 (その他の助成金/資金番号:Czech Health Research Council)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

A deidentified data will be shared at the request of qualified investigators for the purpose of further research.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する